News & Events

BEAM Alliance
Members
Events

Latest news from BEAM Alliance

11 December 2025 - BEAM ALLIANCE

EU Reaches Landmark Agreement on Pharmaceutical Legislation Revision

After a long night of negotiations, EU co-legislators have reached a long-awaited political agreement on the revision of the Union’s…

20 October 2025 - BEAM ALLIANCE

Defining Eligibility for ‘Priority Antimicrobials’: A Critical Step for Effective PULL Incentives

The General Pharmaceutical Legislation (GPL) should provide broad guidelines for eligibility, leaving the EMA to refine the details. The GPL…

20 October 2025 - BEAM ALLIANCE

Transferable Priority Review Vouchers (TPRVs): Lessons from the US, Implications for EU

If a choice must be made, TEEV offer a clearer, more reliable incentive for SMEs, making them a more appealing…

20 October 2025 - BEAM ALLIANCE

The Future of the TEE Voucher in EU Pharmaceutical Legislation

The TEE Voucher is widely supported by SMEs, industry, and investors. Though not perfect, its predictability makes it attractive to…

20 October 2025 - BEAM ALLIANCE

How Can a Subscription Model Help Incentivizing Antimicrobial Innovation in the EU?

An EU-funded revenue guarantee (ensuring predictability and reducing reliance on voluntary participation) could be highly effective, provided the incentives are…

20 October 2025 - BEAM ALLIANCE

The Milestone Prize aimed to Support AMR Innovation Requires Careful Analysis

As things stand, we believe that the milestone prize requires further investigation in order to validate its operational feasibility and…

No results

1 / 10

Latest news of BEAM Members

11 December 2025 - Basilea Pharmaceutica International

Basilea and Phare Bio enter partnership combining anti-infectives industry expertise with unique AI capabilities for the development of a novel antibiotic

We are excited to work with Phare Bio and their innovative platform on the discovery of a new antibiotic. This…

11 December 2025 - BioVersys

BioVersys Announces BV100 Phase 3 Initiation and Provides a Business Update

BV100, the Company’s novel antibiotic candidate, has advanced into a global registration Phase 3 study program in drug-resistant infections. The…

10 November 2025 - BioVersys

BioVersys BV100 Phase 2B to be conducted via Wellcome Funded Trial Network

We are delighted that BV100 was selected by ADVANCE-ID to participate in their clinical trial network in Asia and for…

6 November 2025 - BioVersys

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of Bv100 in China

The timely initiation of the Phase 1 safety and pharmacokinetic study in China demonstrates that the process to eventually include…

4 November 2025 - Basilea Pharmaceutica International

Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea

This further milestone payment for Europe reflects the significant medical need and strong growth momentum of Cresemba in the region.…

22 October 2025 - smartbax

smartbax secures €4.7 million as Germany confronts 10,000 deaths a year from drug-resistant infections

martbax will use the funds to progress its proprietary pipeline of small-molecule antibiotics designed to overcome bacterial resistance with innovative…

No results

1 / 68

Events

17 April 2026

ESCMID Global 2026

ESCMID Global is the world’s premier meeting in the fields of Clinical Microbiology and Infectious Diseases.

3 March 2026

10th AMR Conference

Save the date! The 10th AMR Conference will be organized as a face-to-face event on 3-4 March 2026, in Basel.…

4 February 2026

Antimicrobial Chemotherapy Conference (ACC2026)

Antimicrobial Chemotherapy Conference (ACC2026) is a free, open-access virtual conference, jointly organized with BSAC and in collaboration with ADVANCE-ID and…

27 November 2025

REVIVE Webinar: Data-driven antibiotic discovery: From gaps to solutions

In this webinar the use of data to deliver solutions for antibiotic discovery will be explored.

3 November 2025

BIO-Europe® 2025 – 31st Annual International Partnering Conference

BIO-Europe is the largest, longest-running biopharma partnering conference in Europe. It has evolved with the biotech industry to deliver an…

28 October 2025

REVIVE Webinar: Using artificial intelligence to analyse and predict susceptibility to antimicrobials

This webinar will discuss the emerging technologies in using artificial intelligence to detect antibiotic susceptibility and evaluate their potential for…

No results

1 / 29

Legal notice | Photo credits

Connect with us

contact@beam-alliance.eu
29 Avenue Tony Garnier 69007 Lyon - France